Yongxu Jia
Clinical trials sponsored by Yongxu Jia, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new immunotherapy combo make stomach tumors disappear before surgery? Results expected Sep 2027 (estimated)
-
Can a new immunotherapy combo make stomach tumors disappear before surgery?
Disease control OngoingThis trial is testing whether adding an experimental immunotherapy (QL1706) to a standard chemotherapy regimen (DOS) before surgery can help people with locally advanced stomach or gastroesophageal junction cancer. The goal is to see if the combination can completely eliminate th…
Phase 2 • Sponsor: Yongxu Jia • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New cocktail aims to shrink Hard-to-Treat stomach tumors
Disease control OngoingThis phase 2 trial is testing a combination of three drugs—anlotinib, TQB2450, and the SOX chemotherapy regimen—as a first treatment for advanced stomach or gastroesophageal junction cancer that has low PD-L1 expression. The study involves 37 participants and aims to see how well…
Phase 2 • Sponsor: Yongxu Jia • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC